Delivery Order 75F40125D00013-75F40125F19001

Award Date 9/10/25
Potential Completion Date 9/8/26
Potential Value $247K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20903, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $89,655.00 firm fixed-price purchase order awarded by the Food and Drug Administration to Fujifilm Irvine Scientific, Inc. (doing business as Irvine Scientific) for the purchase of human induced pluripotent stem cell-derived (hiPSC) cells. The contract has a completion date of June 29, 2026 and was awarded on July 1, 2025. Irvine Scientific is a manufacturer of cell culture media, reagents, and medical devices that has received prior federal contract awards to provide specialized...
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent stem cells (iPSCs). The contract has a ceiling value of $119,350.00 and is not set aside for small businesses. The contract is for the supply of "MYCELL AND ICELL...
This is a $124,070 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency under the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC) derived human cell products. The contract is for the delivery of iPSC-derived human neurons and astrocytes, which are biologically relevant cell types used to support biomedical...
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Fujifilm Cellular Dynamics, Inc., a subsidiary of the Japanese conglomerate Fuji Photo Film Company LIMITED. The $79,833 contract is for the supply of pluripotent stem cell and electrophysiology products to support the FDA's biomedical research initiatives, which may include drug development, toxicology screening, antiviral research, and 3D tissue model creation. This specialized contract,...
This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell (iPSC)-derived human cell lines. The $79,500.00 contract is for the supply of human iPSC-derived cardiomyocytes (heart muscle cells) to support biomedical research, drug development, and toxicology screening initiatives. The...
This is a $99,500.00 firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency within the U.S. Department of Health and Human Services, to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell-derived human cell lines. The contract is for the supply of iCell Cardiomyocytes, a specialized cell product used in biomedical research, drug development, and toxicology screening. The contract has...
This is a $50,000.00 firm fixed-price purchase order awarded by the U.S. Environmental Protection Agency's Office of Research and Development to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell-derived human cell products. The contract is for the provision of laboratory supplies and reagents, specifically a range of specialized cell types such as cardiomyocytes, neurons, astrocytes, hepatocytes, and endothelial cells. These cell products...
This federal contract award, valued at $23,850.00, was issued by the Food and Drug Administration (FDA) to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent stem cells (iPSCs). The contract is designated as a Total Small Business set-aside and is for the delivery of CARDIOMYOCYTES, which are specialized cardiac muscle cells. Fujifilm Cellular Dynamics has a strong track record of supplying diverse...
This is a firm-fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Fujifilm Cellular Dynamics, Inc., a foreign-owned, for-profit manufacturer of induced pluripotent stem cell-derived human cell lines. The $11,940 contract is for the supply of cardiomyocytes (heart muscle cells) and does not have a small business set-aside designation. Fujifilm Cellular Dynamics has been a consistent provider of specialized cell products to various federal agencies,...
This federal contract award is for the delivery of iPSC-derived astrocyte cells by Fujifilm Cellular Dynamics, Inc. to the National Center for Advancing Translational Sciences (NCATS), which is a component of the U.S. Department of Health and Human Services. The $24,680 firm fixed price purchase order has an ultimate completion date of October 18, 2024. Fujifilm Cellular Dynamics is a foreign-owned, for-profit manufacturer of biologically relevant human cells derived from induced pluripotent...
  • 75F40125D00013
    Indefinite Delivery Contract
  • 75F40125D00013-75F40125F19001
    Delivery Order

This is a delivery order awarded by the Food and Drug Administration (FDA), a civilian agency, to Fujifilm Irvine Scientific, Inc., a foreign-owned, for-profit manufacturer of goods. The $246,980.00 firm fixed-price contract is for the delivery of human induced pluripotent stem cell-derived (hiPSC) cells. The contract has an ultimate completion date of September 8, 2026. This order was not set aside for any specific business type. Fujifilm Irvine Scientific, Inc. specializes in providing cell culture media, reagents, and medical devices for biomedical research and has previously been awarded other federal contracts by agencies within the Department of Health and Human Services for similar cellular research materials.

Generated 9/11/25, 10:53 AM